DISCOVERIES AND PROGRESS​

Modulation Therapeutics is a clinical stage biotechnology company developing an innovative pipeline of first-in-class therapies to defeat the proliferation mechanisms driving the most aggressive forms of solid tumor cancers and liver disease. New discoveries invented by our team and also in-licensed from leading healthcare institutions are being translated from lab to market through a lean business model, which is lowering costs and accelerating speed of progress.